Schedule iii

Money is flowing into cannabis equities at a pace the sector hasn't seen in years, and the AdvisorShares Pure US Cannabis ETF (MSOS) is the clearest gauge of it. The fund posted a 103.7% one-year net

Tilray Brands moved quickly to position itself inside the U.S. medical cannabis market this week after federal regulators approved a partial rescheduling of marijuana products under the Controlled

Ascend Wellness Holdings has filed applications with the U.S. Drug Enforcement Administration to register its state-licensed medical cannabis operations under the expedited registration pathway tied